{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T01:35:50Z","timestamp":1794274550926,"version":"4.9.0"},"reference-count":20,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","jns-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the Neurological Sciences"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.jns.2025.123493","type":"journal-article","created":{"date-parts":[[2025,4,8]],"date-time":"2025-04-08T13:37:13Z","timestamp":1744119433000},"page":"123493","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["EQ-5D-5L is a relevant tool for detecting patients with myasthenia gravis needing medical treatment"],"prefix":"10.1016","volume":"473","author":[{"given":"Linda Kahr","family":"Andersen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristine Gr\u00f8sfjeld","family":"Petersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva Maria","family":"Deurell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Lagoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna Bundgaard","family":"Kaalund","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ida Finsen","family":"Flensted","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine N\u00f8rrind","family":"Lando","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heini","family":"Borgarl\u00ed\u00f0","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca Kj\u00e6r","family":"Andersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kasper Holst","family":"Axelsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nanna","family":"Witting","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Vissing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.jns.2025.123493_bb0005","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/mus.24697","article-title":"Mortality in myasthenia gravis: a nationwide population-based follow-up study in Denmark","volume":"53","author":"Hansen","year":"2016","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.jns.2025.123493_bb0010","author":"EQ-5D [Internet]"},{"issue":"6","key":"10.1016\/j.jns.2025.123493_bb0015","doi-asserted-by":"crossref","first-page":"3086","DOI":"10.1007\/s00415-021-10902-1","article-title":"Causes of symptom dissatisfaction in patients with generalized myasthenia gravis","volume":"269","author":"Andersen","year":"2022","journal-title":"J. Neurol."},{"issue":"1","key":"10.1016\/j.jns.2025.123493_bb0020","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2022-066445","article-title":"Patient-reported burden of myasthenia gravis: baseline results of the international prospective, observational, longitudinal real-world digital study MyRealWorld-MG","volume":"13","author":"Dewilde","year":"2023","journal-title":"BMJ Open"},{"issue":"1","key":"10.1016\/j.jns.2025.123493_bb0025","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1186\/s13023-023-02727-0","article-title":"Physician- and patient-reported perspectives on myasthenia gravis in Europe: a real-world survey","volume":"18","author":"Mahic","year":"2023","journal-title":"Orphanet J. Rare Dis."},{"issue":"4","key":"10.1016\/j.jns.2025.123493_bb0030","doi-asserted-by":"crossref","first-page":"1818","DOI":"10.1007\/s12325-023-02437-w","article-title":"Association between myasthenia gravis-activities of daily living (MG-ADL) and EQ-5D-5L utility values: the additional effect of Efgartigimod on utilities","volume":"40","author":"Dewilde","year":"2023","journal-title":"Adv. Ther."},{"issue":"3","key":"10.1016\/j.jns.2025.123493_bb0035","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1111\/ene.13836","article-title":"EQ-5D-5L and SF-6D health utility index scores in patients with myasthenia gravis","volume":"26","author":"Barnett","year":"2019","journal-title":"Eur. J. Neurol."},{"issue":"7","key":"10.1016\/j.jns.2025.123493_bb0040","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1212\/WNL.52.7.1487","article-title":"Myasthenia gravis activities of daily living profile","volume":"52","author":"Wolfe","year":"1999","journal-title":"Neurology"},{"issue":"12","key":"10.1016\/j.jns.2025.123493_bb0045","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1056\/NEJM198703193161205","article-title":"Preliminary results of a double-blind, randomized, placebo-controlled trial of cyclosporine in myasthenia gravis","volume":"316","author":"Tindall","year":"1987","journal-title":"N. Engl. J. Med."},{"issue":"6","key":"10.1016\/j.jns.2025.123493_bb0050","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1002\/mus.25198","article-title":"International clinimetric evaluation of the MG-QOL15, resulting in slight revision and subsequent validation of the MG-QOL15r","volume":"54","author":"Burns","year":"2016","journal-title":"Muscle Nerve"},{"issue":"8","key":"10.1016\/j.jns.2025.123493_bb0055","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1016\/j.nmd.2021.05.007","article-title":"Fatigue, physical activity and associated factors in 779 patients with myasthenia gravis","volume":"31","author":"Andersen","year":"2021","journal-title":"Neuromuscul. Disord."},{"issue":"4","key":"10.1016\/j.jns.2025.123493_bb0060","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1007\/s40258-021-00639-3","article-title":"The Danish EQ-5D-5L value set: a hybrid model using cTTO and DCE data","volume":"19","author":"Jensen","year":"2021","journal-title":"Appl. Health Econ. Health Policy"},{"issue":"3","key":"10.1016\/j.jns.2025.123493_bb0065","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/0022-3999(94)00125-O","article-title":"The multidimensional fatigue inventory (MFI) psychometric qualities of an instrument to assess fatigue","volume":"39","author":"Smets","year":"1995","journal-title":"J. Psychosom. Res."},{"issue":"2\u20133","key":"10.1016\/j.jns.2025.123493_bb0070","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S0165-0327(00)00309-8","article-title":"The sensitivity and specificity of the major depression inventory, using the present state examination as the index of diagnostic validity","volume":"66","author":"Bech","year":"2001","journal-title":"J. Affect. Disord."},{"issue":"2","key":"10.1016\/j.jns.2025.123493_bb0075","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1017\/S0033291702006724","article-title":"The internal and external validity of the major depression inventory in measuring severity of depressive states","volume":"33","author":"Olsen","year":"2003","journal-title":"Psychol. Med."},{"issue":"1","key":"10.1016\/j.jns.2025.123493_bb0080","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1097\/ALN.0000000000001159","article-title":"How much better is good enough?: patient-reported outcomes, minimal clinically important differences, and patient acceptable symptom states in perioperative research","volume":"125","author":"Wijeysundera","year":"2016","journal-title":"Anesthesiology"},{"issue":"6","key":"10.1016\/j.jns.2025.123493_bb0085","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.1007\/s00415-020-09767-7","article-title":"Depression in myasthenia gravis: a heterogeneous and intriguing entity","volume":"267","author":"Gavrilov","year":"2020","journal-title":"J. Neurol."},{"issue":"2","key":"10.1016\/j.jns.2025.123493_bb0090","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1177\/14034948211058060","article-title":"Danish population health measured by the EQ-5D-5L","volume":"51","author":"Jensen","year":"2023","journal-title":"Scand. J. Public Health"},{"issue":"5","key":"10.1016\/j.jns.2025.123493_bb0095","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1002\/mus.27331","article-title":"Gender differences in clinical outcomes in myasthenia gravis: aprospective cohort study","volume":"64","author":"Thomsen","year":"2021","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.jns.2025.123493_bb0100","author":"Danskernes Sundhed [Internet]"}],"container-title":["Journal of the Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X25001108?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X25001108?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,20]],"date-time":"2025-05-20T15:59:22Z","timestamp":1747756762000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022510X25001108"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":20,"alternative-id":["S0022510X25001108"],"URL":"https:\/\/doi.org\/10.1016\/j.jns.2025.123493","relation":{},"ISSN":["0022-510X"],"issn-type":[{"value":"0022-510X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"EQ-5D-5L is a relevant tool for detecting patients with myasthenia gravis needing medical treatment","name":"articletitle","label":"Article Title"},{"value":"Journal of the Neurological Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jns.2025.123493","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"123493"}}